At the symposium, Shi Yuanyuan, chairman of our company, first expressed sincere welcome to the leaders and entrepreneurs of Xiangjiang New District, Hunan Province. Chairman Shi Yuanyuan gave a comprehensive description on the industry background, development prospect, clinical application, core technical advantages of Shenzhen Cell Valley and other aspects of cell therapy, and said that cell therapy as an emerging future industry, with the maturity of technology, the market prospect is increasingly broad. Shenzhen Cell Valley has a complete production process system, mature inspection and testing technology, strong scientific and technological research and development strength, to provide customers with high-quality services, to achieve the transformation of cell therapy products, to promote the development of cell therapy products. At present, the cell products based on retroviral vector technology produced by Shenzhen Cell Valley have been successfully applied in clinical practice, bringing new hope for patient treatment. Director Shuai Jun highly appreciated the cutting-edge technology of Shenzhen Cell Valley, fully affirmed the advantages of Shenzhen Cell Valley in cell therapy, industrial layout, technological innovation, talent training and other aspects, and said that gene and biotechnology is one of the seven frontier areas targeted by science and technology in China's "14th Five-Year Plan". It is also an important aspect of Hunan to build a scientific and technological innovation highland with core competitiveness. At present, Hunan's industry-university-research and medical chain is relatively complete, providing a broad platform for promoting the deep integration and development of industry-university-research and medical in the field of cell and gene. Through this inspection and exchange activities, we will have a deeper understanding of the relevant situation and development bottlenecks of the industry, so as to further improve the relevant normative regulations, management systems and mechanisms, and jointly promote the high-quality development of the industry with the relevant management agencies of various provinces and cities and biomedical enterprises.

The event was successfully held. All participants had in-depth exchanges and discussions on the future development trend, clinical research and application experience of the cell and gene therapy industry, and jointly contributed to human health.